Related Experiment Video
Updated: Apr 15, 2026

08:31
Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
11.6K
Development of a simple, biocompatible and cost-effective Inulin-Diethylenetriamine based siRNA delivery system
C Sardo1, R Farra2, M Licciardi1
1Dipartimento di Scienze e Tecnologie Biologiche, Chimiche, Farmaceutiche (STEBICEF), Lab of Biocompatible Polymers, University of Palermo, via Archirafi 32, 90123 Palermo, Italy.
Summary
A novel inulin-based delivery system effectively carries small interfering RNAs (siRNAs) into cancer cells, showing promise for disease treatment. This system protects siRNAs and ensures their efficient delivery and therapeutic action.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Molecular Biology
Background:
- Small interfering RNAs (siRNAs) offer therapeutic potential but require effective delivery systems.
- Current delivery methods face challenges in protecting siRNAs from degradation and ensuring cellular uptake.
- Natural polysaccharides represent a promising platform for developing novel siRNA delivery vehicles.
Purpose of the Study:
- To develop and characterize a novel siRNA delivery system based on functionalized inulin.
- To evaluate the efficacy, safety, and cellular uptake mechanisms of the inulin-based system.
- To compare the performance of the delivery system in different cell lines.
Main Methods:
- Inulin was functionalized with diethylenetriamine (DETA) to create Inu-DETA copolymers.
- Inu-DETA/siRNA complexes were formed and characterized for size, charge, and shape.
- Cytotoxicity, gene silencing efficacy, and cellular uptake mechanisms were assessed in 16HBE and JHH6 cells.
Main Results:
- Inu-DETA effectively bound siRNAs, forming polyplexes with optimal delivery at a 4:1 weight ratio.
- The complexes demonstrated high cytocompatibility and efficient siRNA delivery in JHH6 cells.
- Uptake mechanisms in JHH6 (micropinocytosis, clathrin-mediated endocytosis) facilitated cytoplasmic siRNA diffusion and activity.
Conclusions:
- A novel inulin-based siRNA delivery system (Inu-DETA) was successfully developed.
- The system exhibits efficient siRNA delivery and gene silencing in JHH6 cells with negligible cytotoxicity.
- Further in vivo studies are warranted to explore the therapeutic potential of this inulin-based delivery system.
Related Concept Videos
Experimental RNAi
8.4K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.4K
siRNA - Small Interfering RNAs
19.1K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.1K
RNA Interference
28.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.9K

